The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells

Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models

(2014) David J. Klinke et al.   BIOTECHNOLOGY AND BIOENGINEERING

Aberrant Expression of CXCR4 Significantly Contributes to Metastasis and Predicts Poor Clinical Outcome in Breast Cancer

(2014) P. Yang et al.   CURRENT MOLECULAR MEDICINE

Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts

(2013) Inna Y. Gong et al.   BREAST CANCER RESEARCH AND TREATMENT

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

(2013) Ernst A. Lien et al.   BREAST CANCER RESEARCH AND TREATMENT

Endoxifen’s Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens

(2013) John R. Hawse et al.   PLoS One

Downregulation of Steroid Receptor Coactivator-2 Modulates Estrogen-Responsive Genes and Stimulates Proliferation of MCF-7 Breast Cancer Cells

(2013) Ingvild S. Fenne et al.   PLoS One

EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasion

(2013) G. G. Sun et al.   TUMOR BIOLOGY

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

(2012) Jennifer Gjerde et al.   BREAST CANCER RESEARCH AND TREATMENT

PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees

(2012) Huaiyu Mi et al.   NUCLEIC ACIDS RESEARCH

Clinical and biomarker predictors of side effects from tamoxifen

(2011) Wendy Lorizio et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

(2011) Joanne S. L. Lim et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The Kinase SGK1 in the Endoderm and Mesoderm Promotes Ectodermal Survival by Down-Regulating Components of the Death-Inducing Signaling Complex

(2011) T. Endo et al.   Science Signaling

Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells

(2010) Mélanie Demers et al.   AMERICAN JOURNAL OF PATHOLOGY

Tamoxifen Metabolite Isomer Separation and Quantification by Liquid Chromatography−Tandem Mass Spectrometry

(2010) Malgorzata Jaremko et al.   ANALYTICAL CHEMISTRY

Orally administered Endoxifen is a new therapeutic agent for breast cancer

(2010) Ateeq Ahmad et al.   BREAST CANCER RESEARCH AND TREATMENT

Development of a Method for the Quantification of 1α,25(OH)2–Vitamin D3 in Serum by Liquid Chromatography Tandem Mass Spectrometry without Derivatization

(2010) Bruno Casetta et al.   EUROPEAN JOURNAL OF MASS SPECTROMETRY

Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells

(2009) S Romano et al.   CELL DEATH AND DIFFERENTIATION

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia

(2009) B. Bonanni et al.   CLINICAL CANCER RESEARCH

The human keratins: biology and pathology

(2008) Roland Moll et al.   HISTOCHEMISTRY AND CELL BIOLOGY

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a “basal-like” subset?

(2008) Oluwole Fadare et al.   HUMAN PATHOLOGY